文献速递乳腺乳腺X线

维多利亚乳腺筛查项目乳腺断层合成与乳腺X线摄影试点试验参与者的两年随访:乳腺密度分层筛查结局

Two-year follow-up of participants in the BreastScreen Victoria pilot trial of tomosynthesis versus mammography: breast density-stratified screening outcomes.
PubMed 文献 · Br J Radiol · 2023-05-25

该前瞻性试点试验比较乳腺断层合成与乳腺X线摄影筛查,随访24个月发现断层合成筛查敏感度显著高于乳腺X线摄影(86.0% vs 68.0%,p=0.03),间期癌率无显著差异(1.8/1000 vs 3.1/1000,p=0.20),在高密度乳腺中断层合成的癌检出率显著更高且召回率增加仅见于高密度乳腺。

要点

  • 断层合成筛查敏感度86.0%显著高于乳腺X线摄影68.0%(p=0.03)。
  • 高密度乳腺中断层合成癌检出率10.6/1000显著高于乳腺X线摄影3.5/1000(p=0.03)。
  • 断层合成召回率4.2%显著高于乳腺X线摄影3.0%(p<0.001),增加仅见于高密度乳腺(5.6% vs 2.9%)。

核心结论

  • 虽然两筛查组间期癌率无显著差异,但断层合成筛查敏感度显著高于乳腺X线摄影筛查。

研究设计与样本

  • 前瞻性试点试验(ACTRN-12617000947303),2017年8月至2018年11月在Maroondah乳腺筛查中心招募≥40岁接受筛查女性,接受断层合成者为干预组,同期接受乳腺X线摄影者为对照组,从筛查日起随访24个月确认间期癌,并测量自动乳腺密度。

诊断标准与关键数值

  • 断层合成筛查4908例中筛查检出癌48例、间期癌9例;乳腺X线摄影筛查5153例中筛查检出癌34例、间期癌16例。
  • 间期癌率:断层合成1.8/1000(95%CI 0.8-3.5) vs 乳腺X线摄影3.1/1000(95%CI 1.8-5.0),p=0.20。
  • 敏感度:断层合成86.0%(95%CI 74.2-93.7) vs 乳腺X线摄影68.0%(95%CI 53.3-80.5),p=0.03。
  • 癌检出率:断层合成9.8/1000(95%CI 7.2-12.9) vs 乳腺X线摄影6.6/1000(95%CI 4.6-9.2),p=0.08;高密度筛查中分别为10.6/1000 vs 3.5/1000,p=0.03。
  • 召回率:断层合成4.2% vs 乳腺X线摄影3.0%,p<0.001;高密度筛查中分别为5.6% vs 2.9%,p<0.001。

临床应用与阅片要点

  • 作者指出在项目嵌入式试点试验中,断层合成增加的癌检出率和召回率主要见于高密度乳腺筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This follow-up study of BreastScreen Victoria's pilot trial of digital breast tomosynthesis aimed to report interval cancer rates, screening sensitivity, and density-stratified outcomes for tomosynthesis vs mammography screening.

METHODS: Prospective pilot trial [ACTRN-12617000947303] in Maroondah BreastScreen recruited females ≥ 40 years presenting for screening (August 2017-November 2018) to DBT; concurrent screening participants who received mammography formed a comparison group. Follow-up of 24 months from screen date was used to ascertain interval cancers; automated breast density was measured.

RESULTS: There were 48 screen-detected and 9 interval cancers amongst 4908 tomosynthesis screens, and 34 screen-detected and 16 interval cancers amongst 5153 mammography screens. Interval cancer rate was 1.8/1000 (95%CI 0.8-3.5) for tomosynthesis vs 3.1/1000 (95%CI 1.8-5.0) for mammography (p = 0.20). Sensitivity of tomosynthesis (86.0%; 95% CI 74.2-93.7) was significantly higher than mammography (68.0%; 95% CI 53.3-80.5), p = 0.03. Cancer detection rate (CDR) of 9.8/1000 (95%CI 7.2-12.9) for tomosynthesis was higher than that of 6.6/1000 (95%CI 4.6-9.2) for mammography (p = 0.08); density-stratified analyses showed CDR was significantly higher for tomosynthesis than mammography (10.6/1000 vs 3.5/1000, p = 0.03) in high-density screens. Recall rate for tomosynthesis was significantly higher than for mammography (4.2% vs 3.0%, p < 0.001), and this increase in recall for tomosynthesis was evident only in high-density screens (5.6% vs 2.9%, p < 0.001).

CONCLUSION: Although interval cancer rates did not significantly differ between screened groups, sensitivity was significantly higher for tomosynthesis than mammography screening.

ADVANCES IN KNOWLEDGE: In a program-embedded pilot trial, both increased cancer detection and recall rates from tomosynthesis were predominantly observed in high-density screens.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Houssami, Lockie, Giles, et al. Two-year follow-up of participants in the BreastScreen Victoria pilot trial of tomosynthesis versus mammography: breast density-stratified screening outcomes. Br J Radiol. 2023. PMID: 37191331. doi:10.1259/bjr.20230081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。